Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Inhibikase Therapeutics (IKT) Shares Issued (2020 - 2026)

Inhibikase Therapeutics (IKT) has 7 years of Shares Issued data on record, last reported at $2.9 million in Q1 2026.

  • On a quarterly basis, Shares Issued changed N/A to $2.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $3.7 million, a 1041.4% increase, with the full-year FY2025 number at $845468.0, changed N/A from a year prior.
  • Shares Issued reached $2.9 million in Q1 2026 per IKT's latest filing, up from $845318.0 in the prior quarter.
  • Over the last five years, Shares Issued for IKT hit a ceiling of $7.5 million in Q2 2023 and a floor of -$3.6 million in Q3 2024.
  • A 5-year average of $1.0 million and a median of $220874.5 in 2022 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: soared 16988.12% in 2023, then crashed 5159035.71% in 2024.
  • Tracing IKT's Shares Issued over 5 years: stood at -$44142.0 in 2022, then skyrocketed by 101.02% to $452.0 in 2023, then tumbled by 799050.22% to -$3.6 million in 2024, then skyrocketed by 123.41% to $845318.0 in 2025, then soared by 242.78% to $2.9 million in 2026.
  • Business Quant data shows Shares Issued for IKT at $2.9 million in Q1 2026, $845318.0 in Q4 2025, and $150.0 in Q2 2025.